2256 GMT - Ansell's healthcare margins are seen at Jefferies as the driver of the Australia-listed company's earnings beat. Analyst Vanessa Thomson, who has a last-published buy rating on the stock, tells clients in a note that the personal-protective equipment maker benefited from sales of its higher-margin cleanroom gloves. She adds that the bottom end of Ansell's FY27 earnings-per-share guidance range is higher than both her forecast and consensus hopes. Jefferies has a last-published target price of A$38.20. Shares are at A$34.90 ahead of the open.
At the request of the copyright holder, you need to log in to view this content
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.